Mon, Mar 2, 2015, 8:26 AM EST - U.S. Markets open in 1 hr 4 mins

Recent

% | $
Quotes you view appear here for quick access.

Santarus, Inc. (SNTS) Message Board

  • delia.sherry delia.sherry Aug 26, 2013 11:49 AM Flag

    Aug 20 presentation

    Weekly scripts holding steady at 550 per week. Some concern with TRx SNTS got to get to work on that number if they are going to hit 1520 by end of Sept.
    GLTA

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Here are some possible road blocks I see affecting overall sales growth in the coming quarters:

      1. Pharmacists are switching Uceris with symbicort. All they see is Budesonide on the script and switch it instead of filling as written. This is especially true when the pharmacy does not stock Uceris. While this is not a unique issue, I believe it is now costing the company a lot of missed sales opportunities due to its sheer distribution numbers.

      2. There has been so much emphasis on Uceris that the other drugs have suffered in terms of sales growth. Granted, Uceris has tremendous margins and the focus on it has been justified to this point, but I think some attention needs to be diverted back to Zegerid and Glumetza.

      3. There are still many large Gastro's who have not written a single Uceris script many of which site the burden of cost to their patients as a key reason.

      I believe management will and in some cases has already been addressing these issues. For instance, they have recently added sales reps to help double up sales calls in larger markets.

      Sentiment: Buy

      • 3 Replies to tradingbasis
      • Switching uceris with Symbicort? Switching a UC drug for one that treats bronchospasms? "I know your doctor prescribed uceris for your bowel condition, but as a pharmacist, I think you'd be better off on a medication for COPD, even though your history of medication use indicates no prior use of medications to treat any breathing irregularity. As a matter of fact, I think I will also conveniently exchange your Digoxin with 10mg of Zocor." Are you insane? A drug has to be INDICATED for a condition for it to be written for said condition, lest someone be held legally accountable. Last I checked, Symbicort is not INDICATED for symptoms associated with UC. You are many bricks short of a full load.

        Sentiment: Strong Buy

      • longs like another long switched sides.
        welcome short buddie. do you think SNTS will touch $19 ?

      • Point 1: "Pharmacists are switching Uceris with symbicort. All they see is Budesonide on the script and switch it instead of filling as written. This is especially true when the pharmacy does not stock Uceris."
        Are you a pharmacist? This is illegal, symbicort is not generically equivalent to Uceris and contains a second drug used for asthma patients. Any pharmacy can order if they need to fill a Uceris script. How do you come up this. Any pharmacist who substituted Symbicort for Uceris could be brought before the Board and potentially lose their license. The points 2 and 3 are also not worthy really needing to be posted.

    • That is weekly Rx writers of 550. We are now at average 1100 TRx per week in first week of August. We have to the end of Sept to count, Sales will be higher than most are assuming.

      Sentiment: Strong Buy

 
SNTS
31.960.00(0.00%)Dec 31 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.